GLIOGENE - An international consortium to understand familial glioma

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 9, 2007, Pages 1730-1734

  Malmer, Beatrice ^a   Adatto, Phyllis ^b   Armstrong, Georgina ^b   Barnholtz Sloan, Jill ^d   Bernstein, Jonine L ^e   Claus, Elizabeth ^g,h   Davis, Faith ⁱ   Houlston, Richard ^j   Il'yasova, Dora ^k   Jenkins, Robert ^l   Johansen, Christoffer ^m   Lai, Rose ^f   Lau, Ching ^c   McCarthy, Bridget ⁱ   Nielsen, Hanne ^m   Olson, Sara H ^e   Sadetzki, Siegal ⁿ   Shete, Sanjay ^b   Wiklund, Fredrik ^a,o   Wrensch, Margaret ^p   Yang, Ping ^l   Bondy, Melissa ^b   more..

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f NEUROLOGICAL INSTITUTE   (United States)

^g YALE UNIVERSITY   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^j INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^k DUKE CANCER INSTITUTE   (United States)

^l MAYO CLINIC   (United States)

^m INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

ⁿ TEL AVIV UNIVERSITY   (Israel)

^o KAROLINSKA INSTITUTE   (Sweden)

^p UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER LOCALIZATION; CANCER RISK; CARCINOGENESIS; DNA POLYMORPHISM; FAMILIAL CANCER; FAMILY HISTORY; GENE IDENTIFICATION; GENE LOCUS; GENETIC DISORDER; GENETIC LINKAGE; GENOTYPE; GLIOMA; HUMAN; IONIZING RADIATION; LINKAGE ANALYSIS; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; TUBEROUS SCLEROSIS; TUMOR GENE; TURCOT SYNDROME;

BRAIN NEOPLASMS; COHORT STUDIES; EUROPE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GLIOMA; HUMANS; INTERNATIONAL AGENCIES; ISRAEL; LINKAGE (GENETICS); NORTH AMERICA; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34548862570     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0081     Document Type: Short Survey

References (33)

1. Kleihues P, Cavanee WK, editors. Pathology and genetics: tumours of the nervous system. Lyon: IARC; 2000. p. 6.
2. Sadetzki S, Chetrit A, Freedman L, Stovall M, Modan B, Novikov I. Long-term follow-up for brain tumor development following childhood exposure to ionizing radiation for tinea capitis. Radiat Res 2005;163:424-32.
3. Melean G, Sestini R, Ammannati F, Papi L. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin 2004;129:74-84.
4. Choi NW, Schuman LM, Gullen WH. Epidemiology of primary central nervous system neoplasms. II. Case-control study. Am J Epidemiol 1970;91:467-85.
5. Preston-Martin S, Mack W, Henderson BE. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res 1989;49:6137-43.
6. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
7. Malmer B, Gronberg H, Bergenheim AT, Lenner P, Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 1999;81:366-70.
8. Hemminki K, Li X, Collins VP. Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control 2001;12:195-9.
9. Wrensch M, Lee M, Miike R, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 1997;145:581-93.
10. Paunu N, Pukkala E, Laippala P, et al. Cancer incidence in families with multiple glioma patients. Int J Cancer 2002;97:819-22.
11. Malmer B, Iselius L, Holmberg E, Collins A, Henriksson R, Gronberg H. Genetic epidemiology of glioma. Br J Cancer 2001;84:429-34.
12. de Andrade M, Barnholtz JS, Amos CI, Adatto P, Spencer C, Bondy ML. Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 2001;20:258-70.
13. O'Neill BP, Blondal H, Yang P, et al. Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 2002;11:921-4.
14. Thuwe I, Lundstrom B, Walinder J. Familial brain tumour. Lancet 1979;1:504.
15. Thuwe I. Glioma cerebri in an island community [thesis]. Gothenburg (Sweden): Gothenburg University; 1984.
16. Malmer B, Haraldsson S, Einarsdottir E, Lindgren P, Holmberg D. Homozygosity mapping of familial glioma in Northern Sweden. Acta Oncol 2005;44:114-9.
17. Malmer B, Henriksson R, Gronberg H. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology 2002;21:279-86.
18. Paunu N, Lahermo P, Onkamo P, et al. A novel low-penetrance locus for familial glioma at 15q23-q26.3. Cancer Res 2002;62:3798-802.
19. Hill DA, Inskip PD, Shapiro WR, et al. Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev 2003;12:1443-8.
20. Malmer B, Henriksson R, Gronberg H. Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 2003;106:260-3.
21. Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J Med Genet 2000;92:136-41.
22. Bondy ML, Lustbader ED, Buffler PA, Schull WJ, Hardy RJ, Strong LC. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 1991;8:253-67.
23. Kingsley DP, Kendall BE, Fitz CR. Tuberous sclerosis: a clinicoradiological evaluation of 110 cases with particular reference to atypical presentation. Neuroradiology 1986;28:38-46.
24. Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003;63:6643-50.
25. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000;54:71-6.
26. Listernik R, Ferner RE, Grant LT, Gutmann DH. Optic gliomas in neurofibromatosis-1, controversies and recommendations. Ann Neurol 2007;61:189-98.
27. Vahteristo P, Bartkova J, Eerola H, et al. CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002;71:432-8.
28. Sodha N, Houlston RS, Bullock S, et al. Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome. Hum Mutat 2002;20:460-2.
29. Bachinski LL, Olufemi SE, Zhou X, et al. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23. Cancer Res 2005;65:427-31.
30. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A. Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000;25:12-3.
31. Weeks DE, Ott J, Lathrop GM. SLINK: a general simulation program for linkage analysis. Am J Hum Genet 1990;47:A204.
32. Gudbjartsson DF, Thorvaldsson T, Kong A, Gunnarsson G, Ingolfsdottir A. Allegro version 2. Nat Genet 2005;37:1015-6.
33. Schaffer AA. Faster linkage analysis computations for pedigrees with loops or unused alleles. Hum Hered 1996;46:226-35.